Articles with public access mandates - Joshua A HillLearn more
Not available anywhere: 7
Managing hypogammaglobulinemia in patients treated with CAR-T-cell therapy: key points for clinicians
E Kampouri, CS Walti, J Gauthier, JA Hill
Expert Review of Hematology 15 (4), 305-320, 2022
Mandates: Swiss National Science Foundation
Diagnosis of infectious diseases in immunocompromised hosts using metagenomic next generation sequencing-based diagnostics
AM Casto, DN Fredricks, JA Hill
Blood Reviews 53, 100906, 2022
Mandates: US National Institutes of Health
COVID‐19 after hematopoietic cell transplantation and chimeric antigen receptor (CAR)‐T‐cell therapy
E Kampouri, JA Hill, V Dioverti
Transplant Infectious Disease 25, e14144, 2023
Mandates: Swiss National Science Foundation
Human herpesvirus-6 reactivation and disease after allogeneic haematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxis
E Kampouri, D Zamora, ES Kiem, W Liu, S Ibrahimi, RL Blazevic, ...
Clinical Microbiology and Infection 29 (11), 1450. e1-1450. e7, 2023
Mandates: Swiss National Science Foundation
Infectious complications after intensive chemotherapy with CLAG-M versus 7+ 3 for AML and other high-grade myeloid neoplasms
CS Walti, AB Halpern, H Xie, ES Kiem, EL Chung, KG Schonhoff, ...
Leukemia 37 (2), 298-307, 2023
Mandates: US National Institutes of Health
Understanding the clinical significance of cytomegalovirus viremia after chimeric antigen receptor T-cell therapy: Should we be treating a value?
E Kampouri, MJ Boeckh, JA Hill
Clinical Infectious Diseases, ciae030, 2024
Mandates: Swiss National Science Foundation
Multiple transmissions of chromosomally integrated human herpesvirus‐6 in one family
A Rashidi, K Obeid, J Hill, ED Warlick, DJ Weisdorf
Transplant Infectious Disease 20 (1), e12816, 2018
Mandates: US National Institutes of Health
Available somewhere: 81
Multiple early factors anticipate post-acute COVID-19 sequelae
Y Su, D Yuan, DG Chen, RH Ng, K Wang, J Choi, S Li, S Hong, R Zhang, ...
Cell 185 (5), 881-895. e20, 2022
Mandates: Bill & Melinda Gates Foundation, US Department of Defense, US National …
Infectious complications of CD19-targeted chimeric antigen receptor–modified T-cell immunotherapy
JA Hill, D Li, KA Hay, ML Green, S Cherian, X Chen, SR Riddell, ...
Blood, The Journal of the American Society of Hematology 131 (1), 121-130, 2018
Mandates: US National Institutes of Health
Late events after treatment with CD19-targeted chimeric antigen receptor modified T cells
A Cordeiro, ED Bezerra, AV Hirayama, JA Hill, QV Wu, J Voutsinas, ...
Biology of Blood and Marrow Transplantation 26 (1), 26-33, 2020
Mandates: US National Institutes of Health
How I prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies
JA Hill, SK Seo
Blood, The Journal of the American Society of Hematology 136 (8), 925-935, 2020
Mandates: US National Institutes of Health
Use of chimeric antigen receptor T cell therapy in clinical practice for relapsed/refractory aggressive B cell non-Hodgkin lymphoma: an expert panel opinion from the American …
T Jain, M Bar, AJ Kansagra, EA Chong, SK Hashmi, SS Neelapu, M Byrne, ...
Biology of Blood and Marrow Transplantation 25 (12), 2305-2321, 2019
Mandates: US National Institutes of Health
Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis
joshua a hill
Mandates: US National Institutes of Health
The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality
JA Hill, BT Mayer, H Xie, WM Leisenring, ML Huang, T Stevens-Ayers, ...
Blood, The Journal of the American Society of Hematology 129 (16), 2316-2325, 2017
Mandates: US National Institutes of Health
CAR-T–and a side order of IgG, to go?–Immunoglobulin replacement in patients receiving CAR-T cell therapy
JA Hill, S Giralt, TR Torgerson, HM Lazarus
Blood reviews 38, 100596, 2019
Mandates: US National Institutes of Health
Infectious complications following CD19 chimeric antigen receptor T-cell therapy for children, adolescents, and young adults
SB Vora, A Waghmare, JA Englund, P Qu, RA Gardner, JA Hill
Open forum infectious diseases 7 (5), ofaa121, 2020
Mandates: US National Institutes of Health
Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow …
AJ Kansagra, NV Frey, M Bar, TW Laetsch, PA Carpenter, BN Savani, ...
Bone marrow transplantation 54 (11), 1868-1880, 2019
Mandates: US National Institutes of Health
Clinical utilization of chimeric antigen receptor T cells in B cell acute lymphoblastic leukemia: an expert opinion from the European Society for Blood and Marrow …
AJ Kansagra, NV Frey, M Bar, TW Laetsch, PA Carpenter, BN Savani, ...
Biology of Blood and Marrow Transplantation 25 (3), e76-e85, 2019
Mandates: US National Institutes of Health
Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome
MR Hines, TE Knight, KO McNerney, MB Leick, T Jain, S Ahmed, ...
Transplantation and Cellular Therapy 29 (7), 438. e1-438. e16, 2023
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health
Liquid biopsy for invasive mold infections in hematopoietic cell transplant recipients with pneumonia through next-generation sequencing of microbial cell-free DNA in plasma
JA Hill, SC Dalai, DK Hong, AA Ahmed, C Ho, D Hollemon, L Blair, ...
Clinical Infectious Diseases 73 (11), e3876-e3883, 2021
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program